Suppr超能文献

美国“先建立鼻咽窝入路”血液透析通路方法的当代结果。

Contemporary outcomes of a "snuffbox first" hemodialysis access approach in the United States.

机构信息

Division of Vascular and Endovascular Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.

Division of Vascular and Endovascular Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.

出版信息

J Vasc Surg. 2021 Sep;74(3):947-956. doi: 10.1016/j.jvs.2021.01.069. Epub 2021 Mar 2.

Abstract

OBJECTIVE

The Society for Vascular Surgery guidelines for permanent hemodialysis (HD) access creation recommend prioritizing the most distal possible autogenous access to minimize complications and preserve more proximal options. The "snuffbox" arteriovenous fistula (AVF) is the most distal radial artery-cephalic vein AVF. Despite the theoretical benefits of the snuffbox approach, recent trends have been toward upper arm access. Our study sought to investigate the feasibility of a snuffbox-first strategy for HD access in all anatomically appropriate candidates.

METHODS

From January 2016 to August 2019, all patients with end-stage renal disease (ESRD) or pre-ESRD under consideration for HD access were evaluated for a snuffbox-first approach by a team of vascular surgeons and nephrologists at a single, urban academic medical center in the United States. Data were collected prospectively and supplemented by medical record review. A survival analysis was performed to evaluate primary unassisted and secondary patency and clinical and functional maturation. Patients were censored if they had received a kidney transplant or had died. Cox proportional hazards regression was used to determine the risk factors for prolonged clinical maturation and functional maturation.

RESULTS

A total of 55 snuffbox AVFs were created. The median patient age was 60 years (interquartile range [IQR], 52-70 years), and 52.7% of the patients were men. The median follow-up was 369 days (IQR, 166-509 days). The median survival for primary unassisted patency was 90 days (95% confidence interval [CI], 79-111). Secondary patency at 1 year was 92.3% (95% CI, 85.3%-99.9%). The clinical maturation rate at 1 year was 83.7% (n = 55; 95% CI, 66.8%-91.9%), and the functional maturation rate at 1 year was 85.6% (n = 40; 95% CI, 63.3%-94.4%). Of the patients who were pre-ESRD at AVF creation and had initiated HD during the study period, 87.5% had successfully received incident HD with their snuffbox AVF. Twenty-four patients were receiving HD via a catheter at snuffbox creation. Of those patients, the functional maturation rate at 1 year was 82.5% (95% CI, 44.8%-94.4%). The patients had undergone a median of two interventions (IQR, zero to seven interventions) in the first year. Of these, 46.9% were percutaneous angioplasty and 31.2% were side-branch ligation. Diabetes was associated with slower AVF clinical maturation (multivariate hazard ratio, 0.35; 95% CI, 0.15-0.82; P = .016). A larger artery diameter was associated with earlier AVF clinical maturation (multivariate hazard ratio, 6.64; 95% CI, 2.11-20.9).

CONCLUSIONS

A snuffbox-first approach to HD access is a viable option for distal access creation in a cohort of patients requiring HD in the United States. Subsequent ancillary interventions to facilitate access maturation were required for most patients.

摘要

目的

血管外科学会关于永久性血液透析(HD)通路创建的指南建议优先考虑最远端的自体通路,以最大程度地减少并发症并保留更靠近近端的通路选择。“鼻烟盒”动静脉瘘(AVF)是最远端的桡动脉-头静脉 AVF。尽管鼻烟盒方法具有理论上的优势,但最近的趋势一直是采用上臂通路。我们的研究旨在调查在所有解剖学上合适的患者中采用鼻烟盒优先策略进行 HD 通路创建的可行性。

方法

从 2016 年 1 月至 2019 年 8 月,在美国的一家城市学术医疗中心,一组血管外科医生和肾脏病医生对所有终末期肾病(ESRD)或正在考虑进行 HD 通路的 ESRD 前期患者进行了鼻烟盒优先策略的评估。数据进行前瞻性收集,并通过病历回顾进行补充。采用生存分析评估主要无辅助和次要通畅率以及临床和功能成熟度。如果患者接受了肾移植或死亡,则对其进行删失。采用 Cox 比例风险回归确定延长临床成熟度和功能成熟度的风险因素。

结果

共创建了 55 个鼻烟盒 AVF。患者的中位年龄为 60 岁(四分位距 [IQR],52-70 岁),52.7%的患者为男性。中位随访时间为 369 天(IQR,166-509 天)。主要无辅助通畅的中位生存时间为 90 天(95%置信区间 [CI],79-111)。1 年时的次要通畅率为 92.3%(95%CI,85.3%-99.9%)。1 年时的临床成熟率为 83.7%(n=55;95%CI,66.8%-91.9%),1 年时的功能成熟率为 85.6%(n=40;95%CI,63.3%-94.4%)。在 AVF 创建时为 ESRD 前期且在研究期间开始接受 HD 的患者中,87.5%的患者成功地使用鼻烟盒 AVF 接受了 incident HD。24 名患者在鼻烟盒创建时正在通过导管接受 HD。这些患者中,1 年时的功能成熟率为 82.5%(95%CI,44.8%-94.4%)。患者在第一年中接受了中位数为 2 次(IQR,0 至 7 次)干预。其中,46.9%为经皮血管成形术,31.2%为侧支结扎术。糖尿病与 AVF 临床成熟度较慢相关(多变量危险比,0.35;95%CI,0.15-0.82;P=0.016)。动脉直径越大,AVF 临床成熟得越早(多变量危险比,6.64;95%CI,2.11-20.9)。

结论

在美国需要进行 HD 的患者队列中,采用鼻烟盒优先策略进行 HD 通路创建是一种可行的选择。大多数患者需要后续进行辅助介入以促进通路成熟。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验